Volume 11, Number 6—June 2005
Research
Global Spread of Vancomycin-resistant Enterococcus faecium from Distinct Nosocomial Genetic Complex
Table 2
Regression lines |
Parameter estimates | |||||
---|---|---|---|---|---|---|
b0 |
bamp |
bPAI |
bgly |
bepi |
p value |
|
Complex-17 crude | –4.44 | 0 | 0 | 0 | 1.6 | 0.000 |
Corrected for amp | –6.61 | 5.38 | 0 | 0 | 1 | 0.000 |
Corrected for PAI | –6.29 | 5.08 | 1.06 | 0 | 0.84 | 0.038 |
Corrected for gly | –6.07 | 5.12 | 1.01 | –0.45 | 0.83 | 0.316 |
*Amp, ampicillin resistance; PAI, presence of the Enterococcus faecium pathogenicity island; gly, glycopeptide resistance; epi, epidemiologic source (animal surveillance, community surveillance, hospital surveillance, clinical sample, hospital outbreak).
Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.